Johnson & Johnson's Imbruvica Scores Expanded FDA Approval for Chronic Graft vs Host Disease Post author:Sam Post published:August 2, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Hemovent Files Two Additional Patent Applications For Its Portable ECMO Device For Both Circulatory And Respiratory Support March 21, 2017 Collegium Announces Additional Managed Care Coverage For Xtampza ER For Medicare Part D Patients May 31, 2017 DxTerity Collaborates With On The Development Of A Cancer Genomic Blood Test To Predict Response To Radiation Therapy September 21, 2017
Hemovent Files Two Additional Patent Applications For Its Portable ECMO Device For Both Circulatory And Respiratory Support March 21, 2017
Collegium Announces Additional Managed Care Coverage For Xtampza ER For Medicare Part D Patients May 31, 2017
DxTerity Collaborates With On The Development Of A Cancer Genomic Blood Test To Predict Response To Radiation Therapy September 21, 2017